ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.662,38
0,08%
S&P 500
5.431,60
-0,04%
US Dollar vs BRL
5,35049
0,00%
Bitcoin
66.196,19
0,01%
Brent Oil
82,275
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. AMEX
  6. Javelin Pharmaceuticals (JAV)

  7. Javelin Pharmaceuticals (JAV) Notícias

JAV

Javelin Pharmaceuticals (JAV)

Javelin Pharmaceuticals
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:JAV
DataHoraFonteTítuloCódigoCompanhia
07/07/201007:00Edgar (US Regulatory)Notice of Effectiveness (EFFECT)AMEX:JAVJavelin Pharmaceuticals
06/07/201014:14Edgar (US Regulatory)(25-NSE)AMEX:JAVJavelin Pharmaceuticals
02/07/201017:39Edgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)AMEX:JAVJavelin Pharmaceuticals
02/07/201017:24Edgar (US Regulatory)Post-Effective Amendment to Registration Statement (POS AM)AMEX:JAVJavelin Pharmaceuticals
02/07/201016:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:JAVJavelin Pharmaceuticals
02/07/201016:24Edgar (US Regulatory)Current report filing (8-K)AMEX:JAVJavelin Pharmaceuticals
01/07/201018:20Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)AMEX:JAVJavelin Pharmaceuticals
01/07/201015:59Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)AMEX:JAVJavelin Pharmaceuticals
01/07/201009:05Business WireJavelin Pharmaceuticals, Inc. Announces Successful Completion of Tender Offer for Its Common Stock by Hospira, Inc.AMEX:JAVJavelin Pharmaceuticals
30/06/201007:50GlobeNewswire Inc.Javelin Pharmaceuticals Inc. is Today's Focus Stock on MicroStockProfit.comAMEX:JAVJavelin Pharmaceuticals
21/06/201019:23Dow Jones News2nd UPDATE: Business Wire CEO: Reported Fake Release To FBIAMEX:JAVJavelin Pharmaceuticals
21/06/201017:08Dow Jones NewsUPDATE: Business Wire CEO: Reported Fake Release To FBIAMEX:JAVJavelin Pharmaceuticals
21/06/201011:33Dow Jones NewsBusiness Wire CEO: Reported Fake Release To FBIAMEX:JAVJavelin Pharmaceuticals
21/06/201009:30Business WireNews Release Service Inadvertently Issues Hoax Press Release Identifying Javelin Pharmaceuticals as IssuerAMEX:JAVJavelin Pharmaceuticals
11/06/201010:00Business WireJavelin Receives $2 Million Loan from HospiraAMEX:JAVJavelin Pharmaceuticals
07/06/201009:30Business WireJavelin Receives Notice from Hospira of Funding of LoanAMEX:JAVJavelin Pharmaceuticals
04/06/201017:05Business WireJavelin Receives Notice From NYSE Amex LLC of Non-ComplianceAMEX:JAVJavelin Pharmaceuticals
03/06/201008:30Business WireJavelin Commences Litigation against Hospira & Discus Acquisition Corporation, Asserts Hospira is in Breach of Merger Agreeme...AMEX:JAVJavelin Pharmaceuticals
26/05/201018:23Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)AMEX:JAVJavelin Pharmaceuticals
24/05/201010:05Business WireJavelin Pharmaceuticals, Inc. Provides Update to Dyloject™ UK Supply ChainAMEX:JAVJavelin Pharmaceuticals
19/05/201009:59Business WireJavelin Pharmaceuticals, Inc. Comments on Tender Offer Extension by HospiraAMEX:JAVJavelin Pharmaceuticals
10/05/201017:16Business WireJavelin Pharmaceuticals, Inc. Reports First Quarter 2010 ResultsAMEX:JAVJavelin Pharmaceuticals
10/05/201016:01Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:JAVJavelin Pharmaceuticals
22/04/201007:02Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)AMEX:JAVJavelin Pharmaceuticals
21/04/201018:06Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)AMEX:JAVJavelin Pharmaceuticals
19/04/201018:20Business WireKendall Law Group Investigating Javelin Pharmaceuticals, Inc. Merger AgreementAMEX:JAVJavelin Pharmaceuticals
19/04/201017:44Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)AMEX:JAVJavelin Pharmaceuticals
19/04/201013:47Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)AMEX:JAVJavelin Pharmaceuticals
19/04/201010:49Dow Jones NewsJavelin, Myriad Officially Terminate Buyout DealAMEX:JAVJavelin Pharmaceuticals
19/04/201009:50Business WireJavelin Pharmaceuticals Announces Termination of Merger Agreement with Myriad Pharmaceuticals, Cancels Special Meeting of Sto...AMEX:JAVJavelin Pharmaceuticals
 Apresentando as notícias mais relevantes sobre:AMEX:JAV

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
CMIN3
CSN Mineracao S.A ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados